Giuseppe Viale

112.8k citations
768 papers · 55.3k indexed · 23 hit papers · h-index 113

Impact in

  • Cancer Research top 0.01%
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.01%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Breast Cancer Treatment Studies 313
    • Cancer Genomics and Diagnostics 67
    • HER2/EGFR in Cancer Research 187
    • Cancer Treatment and Pharmacology 65

Giuseppe Viale

756 papers receiving 54.0k citations

Hit Papers

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study 2022 · 204 citations
204199620262006201610002.0k3.0k

Peers

Giuseppe Viale
Comparison fields: 5 of 186
  • Cancer Research 26.1k
  • Oncology 29.3k
  • Pathology and Forensic Medicine 12.6k
  • Radiology, Nuclear Medicine and Imaging 7.0k
  • Pulmonary and Respiratory Medicine 9.5k
Replace Gabriel N. Hortobágyi with:
Gabriel N. Hortobágyi United States
Larry Norton United States
Daniel F. Hayes United States
Matt van de Rijn United States
Gary M. Clark United States
Norman Wolmark United States
Stuart J. Schnitt United States
Razelle Kurzrock United States
Jorge S. Reis‐Filho United States
Carlos Cordon‐Cardo United States
Giuseppe Viale relative to Gabriel N. Hortobágyi United States Gabriel N. Hortobágyi's profile →
Citations per field
00.5×1.5×
Gabriel N. Hortobágyi · 1×
Citations per year

Countries citing papers authored by Giuseppe Viale

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Viale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Viale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Viale more than expected).

Fields of papers citing papers by Giuseppe Viale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Viale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Viale. The network helps show where Giuseppe Viale may publish in the future.

Co-authors

The 25 scholars most cited alongside Giuseppe Viale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giuseppe Viale Line = papers co-authored together Giuseppe Viale links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2 20231
3 202310
4 20227
5
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Hit paper breakdown →
2022204
6 20223
7 202021
8 2018110
9 201626
10 20161
11 201527
12
A gut-vascular barrier controls the systemic dissemination of bacteria
Hit paper breakdown →
2015511
13 2014292
14
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Hit paper breakdown →
20131213
15 2012195
16 201010
17
Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer.
200914
18 200876
19
Effectiveness of LigaSure diathermy coagulation in liver surgery.
200812
20 2006150

About Giuseppe Viale

Giuseppe Viale is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology, having authored 768 papers that have together received 55.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (313 papers), HER2/EGFR in Cancer Research (187 papers), Breast Lesions and Carcinomas (125 papers), Advanced Breast Cancer Therapies (69 papers), Cancer Genomics and Diagnostics (67 papers), Cancer Treatment and Pharmacology (65 papers), Estrogen and related hormone effects (63 papers) and Monoclonal and Polyclonal Antibodies Research (50 papers). The work is most often cited by research in Cancer Research (26.1k citations), Oncology (29.3k citations), Pathology and Forensic Medicine (12.6k citations), Radiology, Nuclear Medicine and Imaging (7.0k citations) and Pulmonary and Respiratory Medicine (9.5k citations). Giuseppe Viale has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Alberto Luini, Paolo Veronesi, Viviana Galimberti, Aron Goldhirsch, Umberto Veronesi, Stefano Zurrida, Giovanni Paganelli, Patrick Maisonneuve, Mitch Dowsett and Mattia Intra. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Breast and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026